SL

Shuqun Lin

BS Bristol-Myers Squibb: 15 patents #345 of 3,969Top 9%
TB Texas Biotechnology: 3 patents #19 of 36Top 55%
📍 Newtown, PA: #47 of 507 inventorsTop 10%
🗺 Pennsylvania: #3,862 of 74,527 inventorsTop 6%
Overall (All Time): #254,171 of 4,157,543Top 7%
18
Patents All Time

Issued Patents All Time

Showing 1–18 of 18 patents

Patent #TitleCo-InventorsDate
RE47929 Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFNα responses Ryan M. Moslin, David S. Weinstein, Stephen T. Wrobleski, John S. Tokarski, Steven H. Spergel +1 more 2020-04-07
10526321 Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses Stephen T. Wrobleski 2020-01-07
10308652 Tricyclic heterocyclic compounds useful as inhibitors of TNF Stephen T. Wrobleski, Gregory D. Brown, Jingwu Duan, Zhonghui Lu, Murali T. G. Dhar +2 more 2019-06-04
10000480 Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses Ryan M. Moslin, David S. Weinstein, Stephen T. Wrobleski, John S. Tokarski, Amit Kumar +5 more 2018-06-19
9505748 Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFNα responses Ryan M. Moslin, David S. Weinstein, Stephen T. Wrobleski, John S. Tokarski, Steven H. Spergel +1 more 2016-11-29
9315494 Alkyl-amide-substituted pyridyl compounds useful as modulators of IL-12, IL-23 and/or IFNα responses Ryan M. Moslin, David S. Weinstein, Stephen T. Wrobleski, Yanlei Zhang, John S. Tokarski +1 more 2016-04-19
9221826 Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases Stephen T. Wrobleski, Jagabandhu Das, Lidia M. Doweyko, Junqing Guo, John Hynes +6 more 2015-12-29
8987268 Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases Stephen T. Wrobleski, Jagabandhu Das, Jingwu Duan, Junqing Guo, John Hynes +7 more 2015-03-24
8921368 Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases Stephen T. Wrobleski, Gregory D. Brown, Lidia M. Doweyko, Jingwu Duan, Junqing Guo +8 more 2014-12-30
8404689 Heterocyclic amide compounds useful as kinase inhibitors Stephen T. Wrobleski, Jagabandhu Das, T. G. Murali Dhar, Alaric J. Dyckman, John Hynes +2 more 2013-03-26
7935696 Heterocyclic amide compounds useful as kinase inhibitors Stephen T. Wrobleski, Jagabandhu Das, T. G. Murali Dhar, Alaric J. Dyckman, John Hynes +2 more 2011-05-03
7923556 Phenyl-substituted pyrimidine compounds useful as kinase inhibitors Stephen T. Wrobleski, Katerina Leftheris, Liqi He, Steven P. Seitz, Tai-An Lin +1 more 2011-04-12
7723336 Fused heterocyclic compounds useful as kinase modulators Wayne Vaccaro, Zhong Chen, Dharmpal S. Dodd, Tram N. Huynh, James Lin +5 more 2010-05-25
7642257 Phenyl-aniline substituted bicyclic compounds useful as kinase inhibitors Jagabandhu Das, John Hynes, Katerina Leftheris, Stephen T. Wrobleski, Hong Wu 2010-01-05
7419978 Phenyl-aniline substituted bicyclic compounds useful as kinase inhibitors Jagabandhu Das, John Hynes, Katerina Leftheris, Stephen T. Wrobleski, Hong Wu 2008-09-02
6262084 Compounds that inhibit the binding of integrins to their receptors Ronald J. Biediger, Vanessa O. Grabbe, George W. Holland, Jamal Kassir, Karin Keller +5 more 2001-07-17
6194448 N, N-disubstituted amides that inhibit the binding of integrins to their receptors Ronald J. Biediger, Vanessa O. Grabbe, George W. Holland, Jamal Kassir, Timothy Kogan +4 more 2001-02-27
6096773 Compounds that inhibit the binding of integrins to their receptors Ian L. Scott, Bore G. Raju, Ronald J. Biediger, Vanessa O. Grabbe, Jamal Kassir +3 more 2000-08-01